XBiotech Valuation
| XBIT Stock | USD 2.69 0.01 0.37% |
Based on Macroaxis valuation methodology, the entity appears to be undervalued. XBiotech maintains a prevalent Real Value of $6.37 per share. The last-minute price of the entity is $2.69. Our model calculates the value of XBiotech from examining the entity fundamentals such as Shares Owned By Insiders of 36.61 %, current valuation of (80.72 M), and Return On Asset of -0.11 as well as analyzing its technical indicators and probability of bankruptcy. Key fundamental drivers impacting XBiotech's valuation include:
Price Book 0.489 | Enterprise Value | Enterprise Value Ebitda (1.60) | Price Sales 12.2321 | Enterprise Value Revenue 24.051 |
Undervalued
Today
Please note that XBiotech's price fluctuation is moderately volatile at this time. Calculation of the real value of XBiotech is based on 3 months time horizon. Increasing XBiotech's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
XBiotech's intrinsic value may or may not be the same as its current market price of 2.69, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 2.69 | Real 6.37 | Target 18.0 | Hype 2.61 | Naive 2.75 |
The intrinsic value of XBiotech's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence XBiotech's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of XBiotech helps investors to forecast how XBiotech stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of XBiotech more accurately as focusing exclusively on XBiotech's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use XBiotech's intrinsic value based on its ongoing forecasts of XBiotech's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against XBiotech's closest peers.
XBiotech Cash |
|
About XBiotech Valuation
The stock valuation mechanism determines XBiotech's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of XBiotech based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of XBiotech. We calculate exposure to XBiotech's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of XBiotech's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | -2 M | -1.9 M | |
| Pretax Profit Margin | (9.63) | (9.15) | |
| Operating Profit Margin | (9.89) | (9.40) | |
| Net Loss | (9.44) | (8.96) | |
| Gross Profit Margin | 0.75 | 0.46 |
XBiotech Current Valuation Indicators
XBiotech's valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final XBiotech's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as XBiotech, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use XBiotech's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes XBiotech's worth.Additional Tools for XBiotech Stock Analysis
When running XBiotech's price analysis, check to measure XBiotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy XBiotech is operating at the current time. Most of XBiotech's value examination focuses on studying past and present price action to predict the probability of XBiotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move XBiotech's price. Additionally, you may evaluate how the addition of XBiotech to your portfolios can decrease your overall portfolio volatility.